Rubella Testing Market: Overview
Rubella or German measles is a
serious condition (disease) caused by the infection of rubivirus (genus).
Sometimes rubella when passed from pregnant mother to her baby then it is
termed as congenital rubella. Rubella is a contagious disease and can spread
through air or close contact between patient and a healthy individual. Signs
and symptom of rubella include fever, headache, inflammation of the eyes and
muscle or joint pain.
Read Report Overview
- https://www.transparencymarketresearch.com/rubella-diagnostic-testing-market.html
Culture test (nasal or throat
swab culture) and blood test to check the function of immune system are the
major tests performed for the detection of rubella. Women who are pregnant must
undergo rubella test to know the functioning of immune system against rubella
virus. There remains chance of miscarriage or stillbirth for those pregnant
mothers who are suffering from measles as the child may be born with birth
defects.
Presently there is no treatment
option available in the market for the treatment of rubella. Patients are
prescribed acetaminophen for reduction of rubella fever. Rubella can be
prevented with the utilization of measles-mumps-rubella (MMR) vaccine. Rubella
vaccine is recommended for all children and is routinely given when children
are 12 months to 15 months old. Almost everyone who receives the vaccine has
immunity to rubella for his lifetime.
Request Brochure of
Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2935
Rubella Testing Market: Segmentation
The global market for rubella
testing can be segmented as:
By Application
·
·
·
·
Rubella Testing Market: Drivers
The global market for rubella
testing is being driven primarily due to increasing awareness among people and
advancement in diagnostic test. Moreover, government initiatives and support
also accounted for the growth of the global rubella testing market. Pregnant
mother who are suffering from rubella and are unaware about the high risk of
passing the disease from her to unborn baby also contributes significantly in
the market growth.
Request for Custom
Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2935
Centre for Disease Control and
Prevention (CDC) stated that more than 100,000 infants are born with congenital
rubella syndrome (CRS) annually worldwide. World Health Organization (WHO)
revealed that in 1996, the number of countries that have incorporated
rubella-containing vaccines into their routine national immunization program
was 83. Later in 2011, the number was increased to 130 for the incorporation of
rubella-containing vaccines into their routine national immunization.
Rubella Testing Market: Region-wise Outlook
North America dominates the
global market for rubella testing due to strong demand of diagnostic test in
this region. Moreover increasing awareness among people and initiative taken by
the federal government also accounted for the market growth in North American
region. Europe represents the second position in the global rubella testing
market due to increasing awareness among people and extensive government
initiative taken by the European government. For an instance, in October 2010,
WHO Region of the America and Europe has established rubella elimination and
CRS prevention goals for the year 2010 and 2015.
Pre Book Rubella
Testing Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=2935<ype=S
Asia - Pacific is considered as
an untapped market due to lack of awareness among people about rubella testing.
Asian market growth will be fuelled by the presence of untapped opportunities
due to extensive increase in the healthcare infrastructure and growing market
penetration in this region.
Rubella Testing Market: Key Players
Major market players contributing
in the global market share of rubella testing market includes Abbott
Laboratories, Inc., Becton, Dickinson and Company, Biomerica, Inc., bioMerieux,
Inc., Novartis Diagnostics, Johnson & Johnson Diagnostics, Inc., Olympus
Corporation, Qiagen N.V., Siemens AG, Thermo Fischer Scientific, Inc., and
Zenith Healthcare Ltd.
About Us
Transparency Market Research is a
global market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for several decision makers.
Our experienced team of analysts, researchers, and consultants use proprietary data
sources and various tools and techniques to gather and analyze information.
Our data repository is
continuously updated and revised by a team of research experts so that it
always reflects latest trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research material
for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
